Results 191 to 200 of about 1,424,356 (264)
Telemedicine documentation in neurology and telestroke: a global scoping review. [PDF]
de Andrade JBC +6 more
europepmc +1 more source
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens +6 more
wiley +1 more source
Turbidity and streamflow as real-time indicators of microbial risk for aquatic recreators. [PDF]
Anderson ES, Jones CS, Hruby CE.
europepmc +1 more source
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober +16 more
wiley +1 more source
Fast, easy and green method for the first quantification of niacinamide in serums and creams by digital image analysis using iron (III) chloride. [PDF]
Lambarri A +4 more
europepmc +1 more source
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi +14 more
wiley +1 more source
Optical frequency combs: Driving precision across the fundamental and applied research domains
Tara Fortier, Victor Torres-Company
doaj +1 more source
The Importance of Content Validity in Accredited Continuing Medical Education/Continuing Professional Development (CME/CPD). [PDF]
Schaefer R +7 more
europepmc +1 more source
MITF maintains genome stability in nonmelanocyte lineages
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir +13 more
wiley +1 more source
ToxBase: A Multidimensional ToxCast Reference Database for High-Throughput Human Exposome Analysis. [PDF]
Nguyen R +12 more
europepmc +1 more source

